showed a trendP = 0.051
Additionally, a lower DLCO%pred at 3 months showed a trend towards predicting higher RVD risk, with borderline statistical significance (OR = 0.95, 95% CI 0.90-1.00, P = 0.051).
Additionally, a lower DLCO%pred at 3 months showed a trend towards predicting higher RVD risk, with borderline statistical significance (OR = 0.95, 95% CI 0.90-1.00, P = 0.051).
While no statistically significant associations were confirmed, elevated ET-1 levels showed a trend toward association ( P = 0.051), with higher ET-1 concentrations correlating with an increased likelihood of disease.
Beyond these core factors, atypical sensory seeking showed a trend-level association with lower general and social adaptive functioning (GAC p = 0.051; SAD p = 0.085).
For the type of comorbidities, non-OA musculoskeletal diseases were associated with the presence of ROA and significant functional disability (ORs 1.63; 1.82) and showed a trend to predict incident ROA (OR 1.84, 95% confidence interval 1.00–3.38 p = 0.051).
However, the frequency of HIV-1 inter-subtype recombinant viruses in the HIV-1 pol gene (26.7%) showed a trend to be higher (p = 0.051; Fisher exact test) than the frequency observed in the HIV-1 env gene (8.6%) in the same population [21] .
Specifically, patients with hypomethylation showed a trend toward more frequent foot amputations (43.9% versus 27.6%; p = 0.051).
Peak acceleration increased when opening the fingers (opening, 22048 mm/s 2 , closing, 17400 mm/s 2 , factor finger movement: F(1, 26)=21.2, p=0.00009), whereas peak velocity showed a trend to decrease (965 versus 1028 mm/s; factor finger movement: F(1,26)= 4.0, p=0.051).
Interestingly the co-culture group showed a trend of upregulation of the basal-specific epidermal marker KRT14 with 0.4 folds over the 100% group ( p -value = 0.051; Figure 2 g) while it kept the same upregulation pattern in comparison to the 0% group ( p -value = 0.0005; Figure 2 g).
Among the time-domain measures, high HR max –HR min [odds ratio (OR), 0.579; 95% confidence interval (CI), 0.405–0.828; p = 0.003], SDNN (OR, 0.725; 95% CI, 0.578–0.909; p = 0.005), STD (OR, 0.044; 95% CI, 0.004–0.559; p = 0.016), and RMSSD (OR, 0.858; 95% CI, 0.755–0.975; p = 0.019) were associated with a low risk of PD, independent of age and sex, whereas pNN50 showed a trend of negative association with the risk of PD (OR, 0.784; 95% CI, 0.614–1.001; p = 0.051).
Three-back accuracy was significantly improved in individuals with EOS ( Z = −2.157, p = 0.031), whereas typically developing adolescents showed a trend of accuracy improvement ( Z = −1.949, p = 0.051) ( Table 1 ).
The Kruskal–Wallis test showed no effect of LPS, and the multiple comparisons only showed a trend in the difference between 50 and 800 μg/mL LPS ( p = 0.051).
unfavorable) showed a trend toward the independent association of MALAT1 expression with TTFT in U-CLL (hazard ratio (HR) = 0.581, 95% CI = 0.337−1.002, p = 0.051).
( 72 ) Aramchol decreased liver fat and improved liver enzymes, and the 600 mg daily dose showed a trend toward higher NASH resolution rates compared to placebo (16.7% and 5%, respectively, P = 0.051).
Participants did not increase positive affect after compared to before the experiment ( Figure 2 A, Table S1 ; PANAS-P, before: 56.4 ± 12.4, after: 56.7 ± 13.4, paired one-tailed t-test, t 19 = 0.13, p = 0.89), but showed a trend decrease in negative affect (PANAS-N, before: 20.5 ± 3.1, after: 19.4 ± 2.3, paired one-tailed t-test, t 19 = 1.72, p = 0.051).
Accordingly, diffusivity differences in the superior cerebellar peduncle (SCP) showed a trend with tool use (ASD group, AD: p = 0.051), supporting the notion that alterations of the SCP may be related to motor deficits rather than clinical group membership, in contrast to the decreased diffusivities of the middle cerebellar peduncle, which may be more related to autism core symptomatology.
On the other hand, when AD converters were analyzed in comparison with MCI/non‐AD subjects, a former or current smoking habit showed a trend to be a relatively protective factor for the progression to AD ( p = 0.051), even considering only a small cohort of individuals.
Clinical Correlation The GMV alteration in the right putamen significantly positively correlated with the HAM-A score ( r = 0.44, p < 0.05; Figure 1B ), while the GMV alteration in the left IPL showed a trend to was negatively correlated with the HAM-A scores ( r = −0.39, p = 0.051; Figure 1C ).
Research question 2: prediction of uptake, login days, and session completion Uptake Mann‒Whitney U tests showed a trend toward lower treatment readiness for individuals who did not log in than for those people who logged in, z = − 2.63, p = .051.
Preoperative propranolol use showed a trend towards a higher risk of CVE (OR 1.66, 95% CI 1.00–2.77, p = 0.051).
The present study did not reflect recurrence and prognosis; nevertheless, the univariate analysis of RFS showed a trend toward recurrence ( p = 0.051).
The overall improvement of ODI and SRS-30 compared to baseline was similar in both groups (all p > 0.05), however the ERF group showed a trend toward lower improvement of ODI at 1-year postoperatively (17.3 vs 24.6, p = 0.051).
The correlation between the PVI for words with a strong-weak pattern and volume loss in this region showed a trend for significance ( r = −0.600, p = 0.051) ( Figure 5D ).
The MD group showed a trend toward fat mass gain ( p = 0.051), while the VLED/semaglutide group maintained stable fat mass ( p = 0.09).
Additionally, although higher CLR showed a trend towards increased mortality (OR 1.03, p = 0.051), it did not reach statistical significance in the multivariate analysis. 3.4.
Among 48 patients receiving 3L therapy, regorafenib showed a trend toward improved OS over sorafenib (HR, 0.33; 95% CI, 0.11 to 1.02; p=0.051), supported by restricted mean survival time analysis (p=0.028).